Ledger.Open graph →
SEC Form D · filed July 25, 2024

GRO Biosciences Inc

Offering
$60.4M
Sold
$27.4M
Exemption
Rule 506(b)
Industry
Other Technology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Tracey J. Lodie · Cambridge, MAExecKevin J. Bitterman · Cambridge, MADirectorMing J. Fang · Cambridge, MADirectorBruce J. Beutel · Cambridge, MADirectorDan J. Becker · Cambridge, MADirectorDaniel J. Mandell · Cambridge, MAExec · DirectorRakhshita J. Dhar · Cambridge, MADirectorMing J. Fang · Cambridge, MADirectorBruce J. Beutel · Cambridge, MADirectorDan J. Becker · Cambridge, MADirectorTracey J. Lodie · Cambridge, MAExecKevin J. Bitterman · Cambridge, MADirectorDaniel J. Mandell · Cambridge, MAExec · DirectorRakhshita J. Dhar · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗